Trials / Completed
CompletedNCT00239993
A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®
An Open-Label, Randomized, Single Cross-over Study of Warm Compress Versus Usual Injection Site Preparation on Local Injection Site Reactions Among Persons With MS Who Perform Daily Injections of Copaxone®.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Teva Neuroscience, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | glatiramer acetate | |
| PROCEDURE | Warm compress prior to injection of glatiramer acetate |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2005-12-01
- Completion
- 2006-02-01
- First posted
- 2005-10-17
- Last updated
- 2017-02-06
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00239993. Inclusion in this directory is not an endorsement.